Millions of people around the world are still affected by the coronavirus pandemic, also known as COVID-19. As scientists scramble and increase efforts in developing and testing potential treatments and preventative measures, a new study suggests that CBD or cannabis may potentially become a cure for COVID-19.
Forbes reports some scientists are looking into the possibility of CBD becoming a COVID-19 cure or have some health benefits for those who are suffering from severe cases. The researchers then suggested that there are ways that cannabis-derived CBD could help severe coronavirus patients. One of which is the ability to reduce ACE2 expression and pro-inflammatory cytokine production that helps fight the inflammation of the lungs. Another is that it has the potential ability to be an antiviral treatment. However, not many studies have tested these theories.
But recently, the study from researchers at Georgia’s Augusta University suggests that CBD may benefit ARDS, also known as acute respiratory distress syndrome, which happens to be one of the severe symptoms of COVID-19. The researchers tested this theory on mice that were first given a dose of Poly(I:C) to artificially induce ARDS that has similar symptoms to COVID-19 patients. Once the mice were experiencing this syndrome, the researchers then gave them a dose of CBD. They noticed the impact CBD has in treating ARDS, which has resulted in a complete or semi-reversal of symptoms.
“Currently, other than supportive measures, there is no definitive cure for ARDS, illustrating the urgent need for creative and effective therapeutic modalities to treat this complex condition,” said the researchers. However, this study appears to add more weight to the possibility that CBD can be used as a possible cure for this dangerous symptom of COVID-19.
Meanwhile, according to the Russian representative for the World Health Organization Melita Vujnovic, it is possible that the virus may have been dormant all this time before it first broke out in Wuhan, China, in 2019. Chinese scientists, as well as the WHO has been looking into the origins of the virus by partnering to figure out where the virus came from.
Vujnovic explained that the virus was likely present in animals and somehow has passed onto humans. However, it proves difficult to specify when and where this all began.


NASA and SpaceX Target Crew-11 Undocking From ISS Amid Medical Concern
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
FDA Fast-Track Drug Reviews Delayed Over Safety and Efficacy Concerns
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
SpaceX Starship Test Flight Reaches New Heights but Ends in Setback
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Neuralink Expands Brain Implant Trials with 12 Global Patients
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 



